Related Experiment Video
Updated: Aug 30, 2025

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.3K
Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers
Juan Marín-Lahoz1,2,3, Saül Martinez-Horta3,4,5,6, Javier Pagonabarraga3,4,5,6
1Neurology Department, Miguel Servet University Hospital, Zaragoza, Spain.
Annals of Neurology
|September 2, 2022
Summary
The feedback-related negativity (FRN) neurophysiological marker can predict impulse control disorders (ICDs) in Parkinson disease (PD) patients. This finding aids in identifying individuals at higher risk for developing ICDs.
Area of Science:
- Neuroscience
- Clinical Neurology
- Psychiatry
Background:
- Impulse control disorders (ICDs) are a significant concern in Parkinson disease (PD).
- Predictive markers for ICD development in PD are crucial for early intervention.
- The feedback-related negativity (FRN), a neurophysiological marker of incentive processing, has not been extensively studied in relation to ICDs in PD.
Purpose of the Study:
- To investigate whether the FRN can predict the future development of ICDs in patients with Parkinson disease.
- To assess the utility of FRNdiff, a measure derived from FRN signals during a gambling task, as a predictive biomarker for ICDs in PD.
Main Methods:
- A longitudinal cohort of nondemented PD patients without a history of ICDs was recruited.
- FRN signals were recorded during a gambling task, and FRNdiff (difference between losses and gains) was calculated.
- Patients underwent biannual follow-up for 30 months to detect incident ICDs, with survival models used for analysis.
Main Results:
- Eighteen out of 92 patients developed ICDs during the 30-month follow-up.
- Baseline FRNdiff was significantly greater in patients who developed ICDs compared to those who did not (-2.33μV vs -0.84μV, p=0.001).
- FRNdiff significantly predicted ICD development, even after adjusting for dopamine replacement therapy, sex, and age (HR=0.74, p=0.035).
Conclusions:
- Differences in reward processing, as indicated by FRN signals, precede the development of ICDs in Parkinson disease.
- The FRN serves as a valuable neurophysiological marker for identifying PD patients at high risk of developing ICDs.
- This research offers a novel approach to early risk stratification for ICDs in the PD population.
Related Concept Videos
Parkinson's Disease: Treatment
357
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
357
Parkinson's Disease: Overview
679
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
679

